Document:

QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 4.2    
    

BANC OF AMERICA SECURITIES LLC &

J.P. MORGAN SECURITIES INC.
  

  
 

    $250,000,000 AGGREGATE PRINCIPAL AMOUNT
  
    COMPUCREDIT CORPORATION
  
    3.625% CONVERTIBLE SENIOR NOTES
  
    DUE 2025
  
    Resale Registration Rights Agreement
  

dated May 27, 2005    
    

        RESALE
REGISTRATION RIGHTS AGREEMENT, dated as of May 27, 2005, by and among CompuCredit Corporation, a Georgia corporation (together with any successor entity, herein referred to
as the "Company"), and Banc of America Securities LLC and J.P. Morgan Securities Inc., as representatives (together, the
"Representatives") of the several initial purchasers (the "Initial Purchasers") as identified under the
Purchase Agreement (as defined below). 

        Pursuant
to the Purchase Agreement, dated as of May 23, 2005, by and among the Company and Banc of America Securities LLC and J.P. Morgan Securities Inc., as
representatives of Initial Purchasers (the
"Purchase Agreement"), relating to the initial placement (the "Initial Placement") of the Notes (as
defined below), the Initial Purchasers have agreed to purchase from the Company $250,000,000 ($300,000,000 if the Initial Purchasers exercise their option in full) in aggregate principal amount at
maturity of 3.625% Convertible Senior Notes due 2025 (the "Notes"). The Notes will be convertible into fully paid, nonassessable shares of common stock,
no par value per share, of the Company (the "Common Stock"). The Notes will be convertible on the terms, and subject to the conditions, set forth in the
Indenture (as defined herein). To induce the Initial Purchasers to purchase the Notes, the Company has agreed to provide the registration rights set forth in this Agreement pursuant to
Section 5(g) of the Purchase Agreement. 

        The
parties hereby agree as follows: 

        1.    Definitions.    Capitalized terms used in this Agreement without definition shall have their respective meanings
set forth in the Purchase Agreement. As used in this Agreement, the following capitalized terms shall have the following meanings: 

        "Affiliate" of any specified person means any other person which, directly or indirectly, is in control of, is controlled by, or is under
common control with, such specified person. For purposes of this definition, control of a person means the power, direct or indirect, to direct or cause the direction of the management and policies of
such person whether by contract or otherwise; and the terms "controlling" and "controlled" have meanings correlative to the foregoing. 

        "Agreement" means this Resale Registration Rights Agreement. 

        "Amendment Effectiveness Deadline Date" has the meaning set forth in Section 2(f)(i) hereof. 

        "Blue Sky Application" has the meaning set forth in Section 6(a)(i) hereof. 

        "Business Day" has the meaning set forth in the Indenture. 

        "Closing Date" means the date of the first issuance of the Notes. 

        "Commission" means the Securities and Exchange Commission. 

        "Common Stock" has the meaning set forth in the preamble hereto. 

        "Company" has the meaning set forth in the preamble hereto. 

        "Effectiveness Period" has the meaning set forth in Section 2(a)(iii) hereof. 

        "Effectiveness Target Date" has the meaning set forth in Section 2(a)(ii) hereof. 

        "Exchange Act" means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission promulgated
thereunder. 

        "Holder" means a Person who owns, beneficially or otherwise, Transfer Restricted Securities. 

        "Indemnified Holder" has the meaning set forth in Section 6(a) hereof. 

        "Indenture" means the Indenture, dated as of May 27, 2005 between the Company and Wachovia Bank, N.A., as trustee (the
"Trustee"), pursuant to which the Notes are to be issued, as such Indenture is amended, modified or supplemented from time to time in accordance with
the terms thereof. 

        "Initial Purchasers" has the meaning set forth in the preamble hereto. 

        "Liquidated Damages" has the meaning set forth in Section 3(a) hereof. 

        "Liquidated Damages Payment Date" means each May 30 and November 30. 

        "Losses" has the meaning set forth in Section 6(e) hereof. 

        "Majority of Holders" means holders holding over 50% of the aggregate principal amount of the Notes outstanding;  provided,that, for the purpose of this definition, a
holder of shares of Common Stock which constitute Transfer Restricted Securities and issued upon
conversion of the Notes shall be deemed to hold an aggregate principal amount at maturity of the Notes (in addition to the principal amount at maturity of the Notes held by such holder) equal to the
quotient of (x) the number of such shares of Common Stock held by such holder and (y) the conversion rate in effect at the time of such conversion as determined in accordance with the
Indenture. 

        "NASD" means the National Association of Securities Dealers, Inc. 

        "Notes" has the meaning set forth in the preamble hereto. 

        "Notice and Questionnaire" means a written notice executed by the respective Holder and delivered to the Company containing substantially
the information called for by the Selling Securityholder Notice and Questionnaire attached as Appendix A to the Offering Memorandum of the Company dated May 23, 2005 relating to the
Notes. 

        "Notice Holder" means, on any date, any Holder of Transfer Restricted Securities that has delivered a Notice and Questionnaire to the
Company on or prior to such date. 

        "Person" means an individual, partnership, corporation, company, unincorporated organization, trust, joint venture or a government or
agency or political subdivision thereof. 

        "Purchase Agreement" has the meaning set forth in the preamble hereto. 

        "Prospectus" means the prospectus included in the Shelf Registration Statement, as amended or supplemented by any prospectus supplement
and by all other amendments thereto, including post-effective amendments, and all material incorporated by reference into such prospectus. 

        "Record Holder" means with respect to any Liquidated Damages Payment Date, each Person who is a Holder on the 15th day
preceding the relevant Liquidated Damages Payment Date. In the case of a Holder of shares of Common Stock issued upon conversion of the Notes, "Record Holder" shall mean each Person who is a Holder of
shares of Common Stock which constitute Transfer Restricted Securities on the 15th day preceding the relevant Liquidated Damages Payment Date. 

        "Registration Default" has the meaning set forth in Section 3(a) hereof. 

        "Representatives" has the meaning set forth in the preamble hereto. 

        "Securities Act" means the Securities Act of 1933, as amended, and the rules and regulations of the Commission promulgated thereunder. 

        "Shelf Filing Deadline" has the meaning set forth in Section 2(a)(i) hereof. 

        "Shelf Registration Statement" has the meaning set forth in Section 2(a)(i) hereof. 

        "Subsequent Shelf Registration Statement" has the meaning set forth in Section 2(c) hereof. 

        "Suspension Notice" has the meaning set forth in Section 4(c) hereof. 

        "Suspension Period" has the meaning set forth in Section 4(b)(ii) hereof. 

        "TIA" means the Trust Indenture Act of 1939, as amended, and the rules and regulations of the Commission promulgated thereunder, in each
case, as in effect on the date the Indenture is qualified under the TIA. 

        "Transfer Restricted Securities" means each Note and each share of Common Stock issued upon conversion of the Notes until the earlier of: 

        (i)    the
date on which such Note or such share of Common Stock issued upon conversion of the Notes has been effectively registered under the Securities Act and disposed of in
accordance with the Shelf Registration Statement; 

        (ii)   the
date on which such Note or such share of Common Stock issued upon conversion of the Notes is transferred in compliance with Rule 144 under the Securities Act
or may be sold or transferred by a person who is not an affiliate of the Company pursuant to Rule 144 under the Securities Act (or any other similar provision then in force) without any volume
or manner of sale restrictions thereunder; or 

        (iii)  the
date on which such Note or such share of Common Stock issued upon conversion of the Notes ceases to be outstanding (whether as a result of redemption, repurchase
and cancellation, conversion or otherwise). 

        Unless
the context otherwise requires, the singular includes the plural, and words in the plural include the singular. 

        2.    Shelf Registration.    

        (a)   The
Company shall: 

        (i)    as
promptly as practicable (but in no event more than 120 days after the Closing Date) (the "Shelf Filing
Deadline"), cause to be filed a registration statement pursuant to Rule 415 under the Securities Act or any similar rule that may be adopted by the Commission (the
"Shelf Registration Statement"), which Shelf Registration Statement shall provide for the registration and resales, on a continuous or delayed basis, of
all Transfer Restricted Securities held by Holders that have provided the information required pursuant to the terms of Section 2(b) hereof; 

        (ii)   use
its reasonable best efforts to cause the Shelf Registration Statement to be declared effective under the Securities Act by the Commission not later than
210 days after the date hereof (the "Effectiveness Target Date"); and 

        (iii)  use
its reasonable best efforts to keep the Shelf Registration Statement continuously effective, supplemented and amended as required by the Securities Act and by the
provisions of Section 4(b) hereof to the extent necessary to ensure that (A) it is available for resales by the Holders of Transfer Restricted Securities entitled, subject to
Section 2(b), to the benefit of this Agreement and (B) it conforms with the requirements of this Agreement and the Securities Act and the rules and regulations of the Commission
promulgated thereunder as announced from time to time, for a period (the "Effectiveness Period") from the date the Shelf Registration Statement is
declared effective by the Commission until the earliest of: 

        (1)   the
date when the Holders of Transfer Restricted Securities are able to sell all such Transfer Restricted Securities immediately without restriction pursuant to
Rule 144(k) under the Securities Act; or 

        (2)   the
date when all of the Transfer Restricted Securities are registered under the Shelf Registration Statement and disposed of in accordance with the Shelf Registration
Statement or pursuant to Rule 144 under the Securities Act or any similar provision then in force or the Transfer Restricted Securities cease to be outstanding (whether as a result of
redemption, repurchase, conversion or otherwise). 

        The
Company shall be deemed not to have used its reasonable best efforts to keep the Shelf Registration Statement effective during the Effectiveness Period if it voluntarily takes any
action that would result in Holders of Transfer Restricted Securities not being able to offer and sell such Securities at any time during the Effectiveness Period, unless such action is
(x) required by applicable law or otherwise undertaken by the Company in good faith and for valid business reasons (not including 

avoidance
of the Company's obligations hereunder), including the acquisition or divestiture of assets, and (y) permitted by Section 4(b)(ii) hereof. 

        (b)   The
Company shall furnish a written notice to each Holder of the Transfer Restricted Securities not less than thirty (30) days before filing the Shelf
Registration Statement and therein inform each Holder that to have its Transfer Restricted Securities included in the Shelf Registration Statement it must deliver a completed Notice and Questionnaire
to the Company. At the time the Shelf Registration Statement is declared effective, each Holder that has delivered a completed Notice and Questionnaire to the Company (a
"Notice Holder") on or prior to the date fifteenth (15) Business Days prior to such time of effectiveness shall be named as a selling
securityholder in the Shelf Registration Statement and the related Prospectus in such a manner as to permit such Holder to deliver such Prospectus to purchasers of Transfer Restricted Securities in
accordance with applicable law. None of the Company's securityholders (other than the Holders of Transfer Restricted Securities) shall have the right to include any of the Company's securities in the
Shelf Registration Statement. Pursuant to the foregoing, the Company agrees that it shall cause to be filed a registration statement pursuant to Rule 415 under the Securities Act that is
separate and distinct from the Shelf Registration Statement as necessary and to the extent, if at all, requested by Merrill Lynch Mortgage Capital Inc.
("Merrill") in order to register any shares of Common Stock that are issued to Merrill in connection with and otherwise pursuant to its warrant for
2,400,000 shares of the Common Stock and its related registration rights agreement with the Company. 

        (c)   If
the Shelf Registration Statement or any Subsequent Shelf Registration Statement ceases to be effective or fails to be usable for any reason at any time during the
Effectiveness Period (other than because all Transfer Restricted Securities registered thereunder shall have been resold pursuant thereto or shall have otherwise ceased to be Transfer Restricted
Securities), the Company shall use its reasonable best efforts to obtain the prompt withdrawal of any order suspending the effectiveness thereof, and in any event shall within thirty (30) days
of such cessation of effectiveness amend the Shelf
Registration Statement in a manner reasonably expected to obtain the withdrawal of the order suspending the effectiveness thereof, or file an additional Shelf Registration Statement covering all of
the securities that as of the date of such filing are Transfer Restricted Securities (a "Subsequent Shelf Registration Statement"). If a Subsequent
Shelf Registration Statement is filed, the Company shall use its reasonable best efforts to cause the Subsequent Shelf Registration Statement to become effective as promptly as is practicable after
such filing and to keep such Registration Statement (or subsequent Shelf Registration Statement) continuously effective until the end of the Effectiveness Period. 

        (d)   The
Company shall supplement and amend the Shelf Registration Statement if required by the rules, regulations or instructions applicable to the registration form used by
the Company for such Shelf Registration Statement, if required by the Securities Act or as reasonably requested by the Initial Purchasers or by the Trustee on behalf of the Holders of the Transfer
Restricted Securities covered by such Shelf Registration Statement. 

        (e)   The
Company shall cause the Shelf Registration Statement and the related Prospectus and any amendment or supplement thereto, as of the effective date of the Shelf
Registration Statement or such amendment or supplement, (i) to comply in all material respects with the applicable requirements of the Securities Act and (ii) not to contain any untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein (in the case of the Prospectus, in light of the
circumstances under which they were made) not misleading. 

        (f)    Each
Holder agrees that if such Holder wishes to sell Transfer Restricted Securities pursuant to a Shelf Registration Statement and related Prospectus, it will do so
only in accordance with this Section 2(f) and the procedures set forth in Section 4 hereof. Each Holder wishing to sell Transfer Restricted Securities pursuant to a Shelf Registration
Statement and related Prospectus must deliver a Notice and Questionnaire to the Company. In order to be named as a selling 

securityholder
in the Prospectus at the time of effectiveness of the Shelf Registration Statement, the Notice and Questionnaire must be delivered at least fifteen Business Days prior to the
effectiveness of the Shelf Registration Statement. From and after the date the Shelf Registration Statement is declared effective the Company shall, as promptly as practicable after the date a Notice
and Questionnaire is received by the Company, and in any event upon the later of (x) fifteen (15) Business Days after such date or (y) fifteen (15) Business Days after the
expiration of any Suspension Period in effect when the Notice and Questionnaire is delivered or put into effect within fifteen (15) Business Days of such delivery date: 

        (i)    if
required by applicable law, file with the Commission a post-effective amendment to the Shelf Registration Statement or prepare and, if required by
applicable law, file a supplement to the related Prospectus or a supplement or amendment to any document incorporated therein by reference or file any other required document so that the Holder
delivering such Notice and Questionnaire is named as a selling securityholder in the Shelf Registration Statement and the related Prospectus in such a manner as to permit such Holder to deliver such
Prospectus to purchasers of the Transfer
Restricted Securities in accordance with applicable law and, if the Company shall file a post-effective amendment to the Shelf Registration Statement, use its reasonable best effort
to cause such post-effective amendment to be declared effective under the Securities Act as promptly as is practicable, but in any event by the date (the "Amendment
Effectiveness Deadline Date") that is sixty (60) days after the date such post effective amendment is required by this clause to be filed; 

        (ii)   provide
such Holder copies of the any documents filed pursuant to Section 2(f)(i); and 

        (iii)  notify
such Holder as promptly as practicable after the effectiveness under the Securities Act of any post-effective amendment filed pursuant to
Section 2(f)(i); 

provided, that, if such Notice and Questionnaire is delivered during a Suspension Period or a Suspension Period begins within five (5) Business
Days after the delivery of such Notice and Questionnaire, the Company shall so inform the Holder delivering such Notice and Questionnaire and shall take the actions set forth in clauses (i),
(ii) and (iii) above upon expiration of the Suspension Period in accordance with Section 4(b); provided, further, that, if the
Company is required by law to file a post-effective amendment for the sole purpose of adding a Holder, the Company shall not be required to file more than one (1) such
post-effective amendment pursuant to this Section 2(f) during any three (3) month period. Notwithstanding anything contained herein to the contrary, (i) the Company
shall be under no obligation to name any Holder that is not a Notice Holder as a selling securityholder in the Shelf Registration Statement or related Prospectus and (ii) the Amendment
Effectiveness Deadline Date shall be extended by up to five (5) Business Days from the expiration of a Suspension Period (and the Company shall incur no obligation to pay Liquidated Damages
during such extension) if such Suspension Period shall be in effect on the Amendment Effectiveness Deadline Date. 

        3.    Liquidated Damages.    

        (a)   If: 

        (i)    the
Shelf Registration Statement is not filed with the Commission prior to or on the Shelf Filing Deadline; 

        (ii)   the
Shelf Registration Statement has not been declared effective by the Commission prior to or on the Effectiveness Target Date; 

        (iii)  the
Company has failed to perform its obligations set forth in Section 2(f) within the time period required therein; 

        (iv)  any
post-effective amendment to a Shelf Registration Statement filed pursuant to Section 2(f)(i) has not become effective under the Securities
Act on or prior to the Amendment Effectiveness Deadline Date; 

        (v)   except
as provided in Section 4(b)(i) hereof, the Shelf Registration Statement is filed and declared effective but, during the Effectiveness Period, shall
thereafter cease to be effective or fail to be usable for its intended purpose without being succeeded within fifteen (15) Business Days by a post-effective amendment to the Shelf
Registration Statement, a supplement to the Prospectus or a report filed with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act that cures such failure and, in
the case of a post-effective amendment, is itself immediately declared effective; or 

        (vi)  (A)
prior to or on the 45th or 60th day, as the case may be, of any Suspension Period, such suspension has not been terminated or (B) the Suspension Periods
exceed an aggregate of 90 days in any 12-month period; 

(each
such event referred to in foregoing clauses (i) through (vi), a "Registration Default"), the Company hereby agrees to pay interest
("Liquidated Damages") with respect to the Transfer Restricted Securities from and including the day following the Registration Default to but excluding
the earlier of (1) the day on which the Registration Default has been cured and (2) the date the Shelf Registration Statement is no longer required to be kept effective, accruing at a
rate: 

        (A)  in
respect of the Notes, to each holder of the Notes, (x) with respect to the first 90-day period during which a Registration Default shall have
occurred and be continuing, equal to 0.25% per annum of the aggregate principal amount of the Notes, and (y) with respect to the period commencing on the 91st day following the day the
Registration Default shall have occurred and be continuing, equal to 0.50% per annum of the aggregate principal amount of the Notes; provided, that in
no event shall Liquidated Damages accrue at a rate per year exceeding 0.50% of the aggregate principal amount of the Notes; and 

        (B)  in
respect of the Notes that are Transfer Restricted Securities submitted for conversion into Common Stock during the existence of a Registration Default, the holder
will not be entitled to receive any Liquidated Damages with respect to such Common Stock but will receive from the Company on the settlement date with respect to such conversion, accrued and unpaid
Liquidated Damages to the
holders of such Notes calculated in accordance with paragraph (A) to the Conversion Date (as defined in the Indenture) relating to such settlement date. 

        Notwithstanding
anything herein to the contrary, Liquidated Damages will not be payable with respect to a Registration Default relating solely to a failure to register the Common Stock
issuable upon conversion of the Notes. 

        (b)   All
accrued Liquidated Damages shall be paid in arrears to Record Holders by the Company on each Liquidated Damages Payment Date. Upon the cure of all Registration
Defaults relating to any particular Note or share of Common Stock, the accrual of Liquidated Damages with respect to such Note or share of Common Stock will cease. 

        All
obligations of the Company set forth in this Section 3 that are outstanding with respect to any Transfer Restricted Security at the time such security ceases to be a Transfer
Restricted Security shall survive until such time as all such obligations with respect to such Transfer Restricted Security shall have been satisfied in full. 

        The
Liquidated Damages set forth above shall be the exclusive monetary remedy available to the Holders of Transfer Restricted Securities for each Registration Default. 

        4.    Registration Procedures.    

        (a)   In
connection with the Shelf Registration Statement, the Company shall comply with all the provisions of Section 4(b) hereof and shall use its reasonable best
efforts to effect such registration to permit the sale of the Transfer Restricted Securities, and pursuant thereto, shall as expeditiously as possible (but no later than the Shelf Filing Deadline)
prepare and file with the 

Commission
a Shelf Registration Statement relating to the registration on any appropriate form under the Securities Act. 

        (b)   In
connection with the Shelf Registration Statement and any Prospectus required by this Agreement to permit the sale or resale of Transfer Restricted Securities, the
Company shall: 

        (i)    Subject
to any notice by the Company in accordance with this Section 4(b) of the existence of any fact or event of the kind described in
Section 4(b)(iv)(D), use its reasonable best efforts to keep the Shelf Registration Statement continuously effective during the Effectiveness Period; upon the occurrence of any event that would
cause the Shelf Registration Statement or the Prospectus contained therein (A) to contain a material misstatement or omission or (B) not to be effective and usable for resale of Transfer
Restricted Securities during the Effectiveness Period, the Company shall file promptly an appropriate amendment to the Shelf Registration Statement, a supplement to the Prospectus or a report filed
with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act, in the case of clause (A), correcting any such misstatement or omission, and, in the case of either
clause (A) or (B), use its reasonable best efforts to cause such amendment to be declared effective and the Shelf Registration Statement and the related Prospectus to become usable for their
intended purposes as soon as practicable thereafter; 

        (ii)   Notwithstanding
Section 4(b)(i) hereof, the Company may suspend the effectiveness of the Shelf Registration Statement (each such period, a
"Suspension Period"): 

        (x)   if
an event occurs and is continuing as a result of which the Shelf Registration Statement, the Prospectus, any amendment or supplement thereto, or any document
incorporated by reference therein would, in the Company's judgment, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make
the statements therein not misleading, or 

        (y)   the
occurrence or existence of any pending corporate development that, in the reasonable discretion of the Company, makes it necessary to suspend the availability of the
Shelf Registration Statement. 

Upon
the occurrence of any event described in clauses (x) and (y) of this Section 4(b)(ii), the Company shall give notice to the Holders that the availability of the Shelf
Registration Statement is suspended and, upon receipt of any such notice, each Holder agrees not to sell any Transfer Restricted Securities pursuant to the Shelf Registration Statement until such
Holder's receipt of copies of the supplemented or amended Prospectus provided for in this Section 4(b). The Suspension Period shall not exceed 45 days in any three-month period;  provided,that,
in the event the disclosure relates to a previously undisclosed pending material business transaction, the disclosure of which the
Company determines in good faith would be reasonably likely to impede the Company's ability to consummate such transaction, the Company may extend a Suspension Period from 45 days to
60 days; provided, further, that the aggregate of all Suspension Periods shall not exceed an aggregate of 90 days in any
12-month period. The Company shall not be required to specify in the written notice to the Holders the nature of the event giving rise to the Suspension Period and the Holders hereby agree
to hold any communications in response to a notice of a proposed business transaction in confidence; 

        (iii)  Prepare
and file with the Commission such amendments and post-effective amendments to the Shelf Registration Statement as may be necessary to keep the
Shelf Registration Statement effective during the Effectiveness Period; cause the Prospectus to be supplemented by any required Prospectus supplement, and as so supplemented to be filed pursuant to
Rule 424 under the Securities Act, and to comply fully with the applicable provisions of Rules 424 and 430A under the Securities Act in a timely manner; and comply with the provisions of
the Securities Act with respect to the disposition of all of the Notes covered by the Shelf Registration Statement during the applicable period in accordance with 

the
intended method or methods of distribution by the sellers thereof set forth in the Shelf Registration Statement or supplement to the Prospectus; 

        (iv)  Advise
the selling Holders and any Initial Purchaser that has provided in writing to the Company a telephone or facsimile number and address for notices, promptly and,
if requested by such selling Holders, to confirm such advice in writing (which notice pursuant to clauses (B) through (D) below shall be accompanied by an instruction to suspend the use
of the Prospectus until the Company shall have remedied the basis for such suspension): 

        (A)  when
the Prospectus or any Prospectus supplement or post-effective amendment has been filed, and, with respect to the Shelf Registration Statement or any
post-effective amendment thereto, when the same has become effective, 

        (B)  of
any request by the Commission for amendments to the Shelf Registration Statement or amendments or supplements to the Prospectus or for additional information relating
thereto, 

        (C)  of
the issuance by the Commission of any stop order suspending the effectiveness of the Shelf Registration Statement under the Securities Act or of the suspension by any
state securities commission of the qualification of the Transfer Restricted Securities for offering or sale in any jurisdiction, or the threatening or initiation of any proceeding for any of the
preceding purposes, or 

        (D)  of
the existence of any fact or the happening of any event, during the Effectiveness Period, that makes any statement of a material fact made in the Shelf Registration
Statement, the Prospectus, any amendment or supplement thereto, or any document incorporated by reference therein untrue, or that requires the making of any additions to or changes in the Shelf
Registration Statement or the Prospectus in order to make the statements therein (in the case of the Prospectus, in the light of the circumstances under which they were made) not misleading. 

If
at any time the Commission shall issue any stop order suspending the effectiveness of the Shelf Registration Statement, or any state securities commission or other regulatory authority shall issue
an order suspending the qualification or exemption from qualification of the Transfer Restricted Securities under state securities or Blue Sky laws, the Company shall use its reasonable best efforts
to obtain the withdrawal or lifting of such order at the earliest possible time and will provide to each Holder who is named in the Shelf Registration Statement prompt notice of the withdrawal of any
such order; 

        (v)   Make
available at reasonable times for inspection by one or more representatives of the selling Holders, designated in writing by a Majority of Holders whose Transfer
Restricted Securities are included in the Shelf Registration Statement, and any attorney or accountant retained by such selling Holders and any Initial Purchaser participating in any disposition
pursuant to the Shelf Registration Statement, all financial and other records, pertinent corporate documents and properties of the Company as shall be reasonably necessary to enable them to conduct a
reasonable investigation within the meaning of Section 11 of the Securities Act, and cause the Company's officers, directors, managers and employees to supply all information reasonably
requested by any such representative or representatives of the selling Holders, attorney or accountant in connection therewith; provided, however, that
the Company shall have no obligation to deliver information to any selling Holder or representative pursuant to this Section 4(b)(v) unless such selling Holder or representative shall
have agreed in writing to keep all such information confidential; provided, further, that the foregoing inspection and information gathering shall, to
the extent reasonably practicable, be coordinated on behalf of all selling Holders by a law firm or attorney or other representative selected by a majority of the Transfer Restricted Securities being
sold by such Holders; 

        (vi)  If
requested by any selling Holders or either of the Representatives, promptly incorporate in the Shelf Registration Statement or Prospectus, pursuant to a supplement
or 

post-effective
amendment if necessary, such information as such selling Holders may reasonably request to have included therein, including, without limitation, information relating to the
plan of distribution of the Transfer Restricted Securities; provided, however, that the foregoing shall not limit the effect of the second proviso
following subsection (iii) of Section 2(f); 

        (vii) Deliver
to each selling Holder, without charge, as many copies of the Prospectus (including each preliminary Prospectus) and any amendment or supplement thereto as
such selling Holder reasonably may request; subject to any notice by the Company in accordance with this Section 4(b) of the existence of any fact or event of the kind described in
Section 4(b)(iv)(D) or any Suspension Period, the Company hereby consents to the use of the Prospectus and any amendment or supplement thereto by each of the selling Holders in connection with
the offering and the sale of the Transfer Restricted Securities covered by the Prospectus or any amendment or supplement thereto; 

        (viii) Before
any public offering of Transfer Restricted Securities, cooperate with the selling Holders and their counsel in connection with the registration and
qualification of the Transfer Restricted Securities under the securities or Blue Sky laws of such jurisdictions in the United States as the selling Holders
may reasonably request and do any and all other acts or things necessary or advisable to enable the disposition in such jurisdictions of the Transfer Restricted Securities covered by the Shelf
Registration Statement; provided, however, that the Company shall not be required (A) to register or qualify as a foreign corporation or a dealer
of securities where it is not so qualified as of the Closing Date or to take any action that would subject it to the service of process in any jurisdiction where it is not so subject as of the Closing
Date, other than service of process for suits arising out of the Initial Placement or any offering pursuant to the Shelf Registration Statement, or (B) to subject itself to general or unlimited
service of process or to taxation in any such jurisdiction if the Company is not so subject as of the Closing Date; 

        (ix)  Unless
any Transfer Restricted Securities shall be in book-entry form only, cooperate with the selling Holders to facilitate the timely preparation and
delivery of certificates representing Transfer Restricted Securities to be sold and not bearing any restrictive legends (unless required by applicable securities laws); and enable such Transfer
Restricted Securities to be in such denominations and registered in such names as the Holders may request at least two (2) Business Days before any sale of Transfer Restricted Securities; 

        (x)   Use
its reasonable best efforts to cause the Transfer Restricted Securities covered by the Shelf Registration Statement to be registered with or approved by such other
U.S. governmental agencies or authorities as may be necessary to enable the seller or sellers thereof to consummate the disposition of such Transfer Restricted Securities; 

        (xi)  Subject
to Section 4(b)(ii) hereof, if any fact or event contemplated by Section 4(b)(iv)(B) through (D) hereof shall exist or have
occurred, use its reasonable best efforts to prepare a supplement or post-effective amendment to the Shelf Registration Statement or related Prospectus or any document incorporated therein
by reference or file any other required document so that, as thereafter delivered to the purchasers of Transfer Restricted Securities, the Prospectus will not contain an untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading; 

        (xii) Provide
CUSIP numbers for all Transfer Restricted Securities not later than the effective date of the Shelf Registration Statement and provide the Trustee under the
Indenture with certificates for the Notes that are in a form eligible for deposit with The Depository Trust Company; 

        (xiii) Cooperate
and assist in any filings required to be made with the NASD; 

        (xiv) Otherwise
use its reasonable best efforts to comply with all applicable rules and regulations of the Commission and all reporting requirements under the rules and
regulations of the Exchange Act; 

        (xv) Cause
the Indenture to be qualified under the TIA not later than the effective date of the Shelf Registration Statement required by this Agreement, and, in connection
therewith, cooperate with the Trustee and the holders of Notes to effect such changes to the Indenture as may be required for such Indenture to be so qualified in accordance with the terms of the TIA;
and execute and use its reasonable best efforts to cause the Trustee thereunder to execute all documents that may be required to effect such changes and all other forms and documents required to be
filed with the Commission to enable such Indenture to be so qualified in a timely manner. In the event that any such amendment or modification referred to in this
Section 4(b)(xv) involves the appointment of a new trustee under the Indenture, the Company shall appoint a new trustee thereunder pursuant to the applicable provisions of the Indenture; 

        (xvi) Cause
all Common Stock covered by the Shelf Registration Statement to be listed or quoted, as the case may be, on each securities exchange or automated quotation
system on which Common Stock is then listed or quoted; 

        (xvii) Provide
to each Holder upon written request each document filed with the Commission pursuant to the requirements of Section 13 and Section 15 of the
Exchange Act after the effective date of the Shelf Registration Statement, unless such document is available through the Commission's EDGAR system; 

        (xviii) Use
its reasonable best efforts (i) if the Notes have been rated prior to the initial sale of such Notes, to confirm such ratings will apply to the Notes
covered by the Shelf Registration Statement; 

        (xix) Use
its reasonable best efforts to take all other steps necessary to effect the registration of the Notes covered by the Shelf Registration Statement; and 

        (xx) Enter
into customary agreements and take all other appropriate actions in order to expedite or facilitate the registration or the disposition of the Notes. 

        (c)   Each
Holder agrees by acquisition of a Transfer Restricted Security that, upon receipt of any notice (a "Suspension
Notice") from the Company of a Suspension Period, such Holder will forthwith discontinue disposition of Transfer Restricted Securities pursuant to the Shelf Registration
Statement until: 

        (i)    such
Holder has received copies of the supplemented or amended Prospectus contemplated by Section 4(b)(xi) hereof; or 

        (ii)   such
Holder is advised in writing by the Company that the use of the Prospectus may be resumed, and has received copies of any additional or supplemental filings that
are incorporated by reference in the Prospectus. 

If
so directed by the Company, each Holder will deliver to the Company (at the Company's expense) all copies, other than permanent file copies then in such Holder's possession, of the Prospectus
covering such Transfer Restricted Securities that was current at the time of receipt of such notice of suspension. 

        (d)   Each
Holder agrees by acquisition of a Transfer Restricted Security, that no Holder shall be entitled to sell any of such Transfer Restricted Securities pursuant to a
Shelf Registration Statement, or to receive a Prospectus relating thereto, unless such Holder has furnished the Company with a Notice and Questionnaire as required pursuant to Section 2(f)
hereof (including the information required to be included in such Notice and Questionnaire) and the information set forth in the next two sentences. The Company may require each Notice Holder of the
Notes to be sold pursuant to the Shelf Registration Statement to furnish to the Company such information 

regarding
the Holder and the distribution of such Notes as the Company may from time to time reasonably require for inclusion in such Shelf Registration Statement. Each Notice Holder agrees promptly
to furnish to the Company all information required to be disclosed in order to make the information previously furnished to the Company by such Notice Holder not misleading and any other information
regarding such Notice Holder and the distribution of such Transfer Restricted Securities as the Company may from time to time reasonably request in writing. Any sale of any Transfer Restricted
Securities by any Holder shall constitute a representation and warranty by such Holder that the information relating to such Holder and its plan of distribution is as set forth in the Prospectus
delivered by such Holder in connection with such disposition, that such Prospectus does not as of the time of such sale contain any untrue statement of a material fact relating to or provided by such
Holder or its plan of distribution and that such Prospectus does not as of the time of such sale omit to state any material fact relating to or provided by such Holder or its plan of distribution
necessary to make the statements in such Prospectus, in the light of the circumstances under which they were made not misleading. The Company may exclude from such Shelf Registration Statement the
Notes of any Holder that unreasonably fails to furnish such information within a reasonable time after receiving such request. 

        5.    Registration Expenses.    

        All
expenses incident to the Company's performance of or compliance with this Agreement shall be borne by the Company regardless of whether a Shelf Registration Statement becomes
effective, including, without limitation: 

        (i)    all
registration and filing fees and expenses (including filings made with the NASD); 

        (ii)   all
fees and expenses of compliance with federal securities and state Blue Sky or securities laws; 

        (iii)  all
expenses of printing (including printing of Prospectuses and certificates for the Common Stock to be issued upon conversion of the Notes) and the Company's
expenses for messenger and delivery services and telephone; 

        (iv)  all
fees and disbursements of counsel to the Company; 

        (v)   all
application and filing fees in connection with listing (or authorizing for quotation) the Common Stock on a national securities exchange or automated quotation
system pursuant to the requirements hereof; and 

        (vi)  all
fees and disbursements of independent certified public accountants of the Company. 

        The
Company shall bear its internal expenses (including, without limitation, all salaries and expenses of its officers and employees performing legal, accounting or other duties), the
expenses of any annual audit and the fees and expenses of any Person, including special experts, retained by the Company. 

        6.    Indemnification and Contribution.    

        (a)   The
Company agrees to indemnify and hold harmless each Holder of Transfer Restricted Securities (including each Initial Purchaser), its directors, officers, and
employees, Affiliates and agents and each person, if any, who controls any such Holder within the meaning of the Securities Act or the Exchange Act (each, an "Indemnified
Holder"), against any loss, claim, damage, liability or expense, joint or several, or any action in respect thereof (including, but not limited to, any loss, claim, damage,
liability or action relating to resales of the Transfer Restricted Securities), to which such Indemnified Holder may become subject, insofar as any such loss, claim, damage, liability or action arises
out of, or is based upon: 

        (i)    any
untrue statement or alleged untrue statement of a material fact contained in (A) the Shelf Registration Statement as originally filed or in any amendment
thereof, in any Prospectus, or in any amendment or supplement thereto, or (B) any blue sky application or 

other
document or any amendment or supplement thereto prepared or executed by the Company (or based upon written information furnished by or on behalf of the Company expressly for use in such blue sky
application or other document or amendment or supplement) filed in any jurisdiction specifically for the purpose of qualifying any or all of the Transfer Restricted Securities under the securities law
of any state or other jurisdiction (such application or document being hereinafter called a "Blue Sky Application"); or 

        (ii)   the
omission or alleged omission to state therein any material fact required to be stated therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading, 

and
agrees to reimburse each Indemnified Holder promptly upon demand for any legal or other expenses reasonably incurred by such Indemnified Holder in connection with investigating, defending,
settling, compromising or paying any such loss, claim, damage, liability, expense or action; provided, however, that the Company shall not be liable in
any such case to the extent that any such loss, claim, damage, liability or expense arises out of, or is based upon, any untrue statement or alleged untrue statement or omission or alleged omission
made in reliance upon and in conformity with written information furnished to the Company by or on behalf of such Holder (or its related Indemnified Holder) specifically for use therein. The foregoing
indemnity agreement is in addition to any liability which the Company may otherwise have. 

        (b)   Each
Holder, severally and not jointly, agrees to indemnify and hold harmless the Company, its directors, officers and employees and each person, if any, who controls
the Company within the meaning of the Securities Act or the Exchange Act to the same extent as the foregoing indemnity from the Company to each such Holder, but only with reference to written
information relating to such Holder furnished to the Company by or on behalf of such Holder specifically for inclusion in the documents referred to in the foregoing indemnity. This indemnity agreement
set forth in this Section shall be in addition to any liabilities which any such Holder may otherwise have. In no event shall any Holder, its directors, officers or any person who controls such Holder
be liable or responsible for any amount in excess of the amount by which the total amount received by such Holder with respect to its sale of Transfer Restricted Securities pursuant to a Shelf
Registration Statement exceeds (i) the amount paid by such Holder for such Transfer Restricted Securities and (ii) the amount of any damages that such Holder, its directors, officers or
any person who controls such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. 

        (c)   Promptly
after receipt by an indemnified party under this Section 6 of notice of any claim or the commencement of any action, the indemnified party shall, if a
claim in respect thereof is to be made against the indemnifying party under this Section 6, notify the indemnifying party in writing of the claim or the commencement of that action;  provided, however, that the failure to notify the indemnifying party (i) shall not relieve it from any liability which it may have under
paragraphs (a) or (b) of this Section 6 unless and to the extent it did not otherwise learn of such action and such failure materially prejudices the indemnifying party, and
(ii) shall not, in any event, relieve it from any liability that it may have to an indemnified party otherwise than under paragraphs (a) or (b) of this Section 6. If any
such claim or action shall be brought against an indemnified party, and it shall notify the indemnifying party thereof, the indemnifying party shall be entitled to participate therein and, to the
extent that it wishes, jointly with any other similarly notified indemnifying party, to assume the defense thereof with counsel satisfactory to the indemnified party. After notice from the
indemnifying party to the indemnified party of its election to assume the defense of such claim or action, the indemnifying party shall not be liable to the indemnified party under this
Section 6 for any legal or other expenses subsequently incurred by the indemnified party in connection with the defense thereof other than reasonable costs of investigation;  provided, however, that
the indemnified party shall have the right to employ a single counsel to represent jointly the indemnified party and their
officers, employees and controlling persons who may be subject to liability arising out of any claim in respect of which indemnity may be sought by the indemnified party against the Company under this
Section 6 if the indemnified 

party
seeking indemnification shall have been advised by legal counsel that there may be one or more legal defenses available to such indemnified party and their respective officers, employees and
controlling persons that are different from or additional to those available to the Company, and in that event, the fees and expenses of such separate counsel shall be paid by the Company. No
indemnifying party shall, without the prior written consent of the indemnified parties (which consent shall not be unreasonably withheld), settle or compromise or consent to the entry of any judgment
with respect to any pending or threatened claim, action, suit or proceeding in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified parties are
actual or potential parties to such claim or action), unless such settlement, compromise or consent (x) includes an unconditional release of each indemnified party from all liability arising
out of such claim, action, suit or proceeding and (y) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party. 

        (d)   The
indemnifying party under this Section 6 shall not be liable for any settlement of any proceeding effected without its written consent, which shall not be
withheld unreasonably, but if settled with such consent or if there is a final non-appealable judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party
against any loss, claim, damage, liability or expense by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any time an indemnified party shall have requested an
indemnifying party to reimburse the indemnified party for fees and expenses of counsel as contemplated by Section 6(c) hereof that are not being reasonably contested by the indemnifying party,
the indemnifying party agrees that it shall be liable for any settlement of any proceeding effected without its written consent if (i) such settlement is entered into more than 30 days
after receipt by such indemnifying party of the aforesaid request and (ii) such indemnifying party shall not have reimbursed the indemnified party in accordance with such request prior to the
date of such settlement. No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement, compromise or consent to the entry of judgment in any pending
or threatened action, suit or proceeding in respect of which any indemnified party is or could have been a party and indemnity was or could have been sought hereunder by such indemnified party,
unless such settlement, compromise or consent (x) includes an unconditional release of such indemnified party from all liability on claims that are the subject matter of such action, suit or
proceeding and (y) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party. 

        (e)   If
the indemnification provided for in this Section 6 shall for any reason be unavailable or insufficient to hold harmless an indemnified party under Sections
6(a) or 6(b) in respect of any loss, claim, damage or liability (or action in respect thereof) referred to therein, each indemnifying party shall, in lieu of indemnifying such indemnified party,
contribute to the aggregate amount paid or payable by such indemnified party as a result of such loss, claim, damage or liability (including legal or other expenses reasonably incurred in connection
with investigating or defending any loss, claim, liability, damage or action) (collectively "Losses") (or action in respect thereof): 

        (i)    in
such proportion as is appropriate to reflect the relative benefits received by the Company from the offering and sale of the Transfer Restricted Securities on the one
hand and a Holder with respect to the sale by such Holder of the Transfer Restricted Securities on the other; or 

        (ii)   if
the allocation provided by Section (6)(e)(i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative
benefits referred to in Section 6(e)(i), but also the relative fault of the Company on the one hand and the Holders on the other in connection with the statements or omissions or alleged
statements or alleged omissions that resulted in such loss, claim, damage or liability (or action in respect thereof), as well as any other relevant equitable considerations. 

The
relative benefits received by the Company on the one hand and a Holder on the other with respect to such offering and such sale shall be deemed to be in the same proportion as the total net
proceeds from the offering of the Notes purchased under the Purchase Agreement (before deducting expenses) received by the Company, on the one hand, bear to the total proceeds received by such Holder
with respect to its sale of Transfer Restricted Securities on the other. The relative fault of the parties shall be determined by reference to whether the untrue or alleged untrue statement of a
material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company on the one hand or the Holders on the other, the intent of the parties and
their relative knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and each Holder agree that it would not be just and equitable if the
amount of contribution pursuant to this Section 6(e) were determined by pro rata allocation or by any other method of allocation that does not
take into account the equitable considerations referred to in the first sentence of this paragraph (e). 

        The
amount paid or payable by an indemnified party as a result of the loss, claim, damage or liability, or action in respect thereof, referred to above in this Section 6 shall be
deemed to include, for purposes
of this Section 6, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending or preparing to defend any such action or claim. 

        Notwithstanding
the provisions of this Section 6, no Holder shall be required to contribute any amount in excess of the amount by which the total price at which the Transfer
Restricted Securities purchased by it were resold exceeds the amount of any damages that such Holder has otherwise been required to pay by reason of any untrue or alleged untrue statement or omission
or alleged omission. No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not
guilty of such fraudulent misrepresentation. The Holders' obligations to contribute as provided in this Section 6(e) are several and not joint. 

        (f)    The
provisions of this Section 6 shall remain in full force and effect, regardless of any investigation made by or on behalf of any Holder or the Company or any
of the officers, directors or controlling persons referred to in Section 6 hereof, and will survive the sale by a Holder of Transfer Restricted Securities. 

        7.    Rule 144A and Rule 144.    The Company agrees with each Holder, for so long as any Transfer
Restricted Securities remain outstanding and during any period in which the Company (i) is not subject to Section 13 or 15(d) of the Exchange Act, to make available, upon request of any
Holder, to such Holder or beneficial owner of Transfer Restricted Securities in connection with any sale thereof and any prospective purchaser of such Transfer Restricted Securities designated by such
Holder or beneficial owner, the information required by Rule 144A(d)(4) under the Securities Act in order to permit resales of such Transfer Restricted Securities pursuant to Rule 144A,
and (ii) is subject to Section 13 or 15(d) of the Exchange Act, to make all filings required thereby in a timely manner in order to permit resales of such Transfer Restricted Securities
pursuant to Rule 144. Nothing in this Section 7 shall be deemed to require the Company to register any of its securities under the Exchange Act that are not already registered
thereunder. 

        8.    Miscellaneous.    

        (a)   Remedies. The Company acknowledges and agrees that any failure by the Company to comply with its obligations under
Section 2 hereof may result in material irreparable injury to the Initial Purchasers or the Holders for which there is no adequate remedy at law, that it will not be possible to measure damages
for such injuries precisely, and that, in the event of any such failure, in addition to being entitled to exercise all rights provided to it herein, in the Indenture or in the Purchase Agreement or
granted by law, including recovery of liquidated or other damages, the Initial Purchasers or any Holder may obtain such relief as may be required to specifically enforce the Company's obligations
under Section 2 hereof. The Company further agrees to waive the defense in any action for specific performance that a remedy at law would be adequate. 

        (b)   Actions Affecting Transfer Restricted Securities. The Company shall not, directly or indirectly, take any action with
respect to the Transfer Restricted Securities as a class that would adversely affect the ability of the Holders of Transfer Restricted Securities to include such Transfer Restricted Securities in a
registration undertaken pursuant to this Agreement except as otherwise explicitly provided for herein. 

        (c)   No Inconsistent Agreements. The Company has not, as of the date hereof, entered into, nor shall it, on or after the date
hereof, enter into, any agreement with respect to its securities that is inconsistent with the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions hereof. In
addition, the Company shall not grant to any of its securityholders (other than the Holders of Transfer Restricted Securities in such capacity) the right to include any of its securities in the Shelf
Registration Statement provided for in this Agreement other than the Transfer Restricted Securities. 

        (d)   Amendments and Waivers. This Agreement may not be amended, modified or supplemented, and waivers or consents to or
departures from the provisions hereof may not be given, unless the Company has obtained the written consent of a Majority of Holders; provided,  however,
that with respect to any matter that directly or indirectly adversely affects the rights of any Initial Purchaser hereunder, the Company shall
obtain the written consent of each such Initial Purchaser against which such amendment, qualification, supplement, waiver or consent is to be effective. Notwithstanding the foregoing (except the
foregoing proviso), a waiver or consent to depart from the provisions hereof with respect to a matter that relates exclusively to the rights of Holders whose securities are being sold pursuant to a
Shelf Registration Statement and does not directly or indirectly adversely affect the rights of other Holders, may be given by the Majority Holders, determined on the basis of the Notes being sold
rather than registered under such Shelf Registration Statement. 

        (e)   Notices. All notices and other communications provided for or permitted hereunder shall be made in writing by hand
delivery, first class mail (registered or certified, return receipt requested), facsimile transmission, or air courier guaranteeing overnight delivery: 

        (i)    if
to a Holder, at the address set forth on the records of the registrar under the Indenture or the transfer agent of the Common Stock, as the case may be; and 

        (ii)   if
to the Company, at its address set forth in the Purchase Agreement, 

With
a copy to: 

Troutman
Sanders LLP

600 Peachtree Street

Suite 5200

Atlanta, GA 30308-2216

Facsimile: (404) 962-6743

Attention: W. Brinkley Dickerson, Jr. 

        All
such notices and communications shall be deemed to have been duly given: at the time delivered by hand, if personally delivered; five Business Days after being deposited in the mail,
postage prepaid, if mailed; when receipt acknowledged, if transmitted by facsimile; and on the next Business Day, if timely delivered to an air courier guaranteeing overnight delivery. 

        Any
party hereto may change the address for receipt of communications by giving written notice to the others. 

        (f)    Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and assigns of
each of the parties, including without limitation and without the need for an express assignment, subsequent Holders of Transfer Restricted Securities. The Company hereby agrees to extend the benefit
of this Agreement to any Holder and any such Holder may specifically enforce the provisions of this Agreement as if an original party hereto. 

        (g)   Counterparts. This Agreement may be executed in any number of counterparts and by the parties hereto in separate
counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. 

        (h)   Jurisdiction. The Company agrees that any suit, action or proceeding against the Company brought by any Holder or Initial
Purchaser, the directors, officers, employees, Affiliates and agents of any Holder or Initial Purchaser, or by any person who controls any Holder or Initial Purchaser, arising out of or based upon
this Agreement or the transactions contemplated hereby may be instituted in any State or U.S. federal court in The City of New York and County of New York, and waives any objection which it may now or
hereafter have to the laying of venue of any such proceeding, and irrevocably submits to the non-exclusive jurisdiction of such courts in any suit, action or proceeding. Notwithstanding
the foregoing, any action arising out of or based upon this Agreement may be instituted by any Holder or Initial Purchaser, the directors, officers, employees, Affiliates and agents of any Holder or
Initial Purchaser, or by any person who controls any Holder or Initial Purchaser, in any court of competent jurisdiction in the State of Georgia. 

        (i)    Notes Held by the Company or its Affiliates. Whenever the consent or approval of Holders of a specified percentage of
Transfer Restricted Securities is required hereunder, Transfer Restricted Securities held by the Company or its Affiliates (other than subsequent Holders if such subsequent Holders are deemed to be
Affiliates solely by reason of their holding of such Notes) shall not be counted in determining whether such consent or approval was given by the Holders of such required percentage. 

        (j)    Headings. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect
the meaning hereof. 

        (k)   Governing Law. This Agreement shall be governed by and construed in accordance with the law of the State of New York,
without giving consideration to the conflicts of law provisions thereof. 

        (l)    Severability. If any one or more of the provisions contained herein, or the application thereof in any circumstance, is
held invalid, illegal or unenforceable, the validity, legality and enforceability of any such provision in every other respect and of the remaining provisions contained herein shall not be affected or
impaired thereby, it being intended that all of the rights and privileges of the parties shall be enforceable to the fullest extent permitted by law. 

        (m)  Entire Agreement. This Agreement is intended by the parties as a final expression of their agreement and intended to be a
complete and exclusive statement of the agreement and understanding of the parties hereto in respect of the subject matter contained herein. There are no restrictions, promises, warranties or
undertakings, other than those set forth or referred to herein with respect to the registration rights granted by the Company with respect to the Transfer Restricted Securities. This Agreement
supersedes all prior agreements and understandings between the parties with respect to such subject matter. 

        (n)   Termination. This Agreement and the obligations of the parties hereunder shall terminate upon the completion of the
Effectiveness Period, except for liabilities on obligations under Sections 3, 4(d), 5, 6 and 9, each of which shall remain in effect in accordance with its terms. 

        IN
WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above. 

	

COMPUCREDIT CORPORATION
	

 	
 	

By	

/s/  RICHARD R. HOUSE, JR.      
Name: Richard R. House, Jr.
 Title: President
	

 	
 	

BANC OF AMERICA SECURITIES LLC &

J.P. MORGAN SECURITIES INC.

Acting severally on behalf of themselves and the several Initial Purchasers
	

 	
 	

By:	

BANC OF AMERICA SECURITIES LLC
	

 	
 	

By	

/s/  DEREK S. DILLON      
Authorized Representative
	

 	
 	

By:	

J.P. MORGAN SECURITIES INC.
	

 	
 	

By	

/s/  JEFFREY ZAJKOWSKI      
Authorized Representative

QuickLinks

Exhibit 4.2

$250,000,000 AGGREGATE PRINCIPAL AMOUNT COMPUCREDIT CORPORATION 3.625% CONVERTIBLE SENIOR NOTES DUE 2025 Resale Registration Rights Agreement dated May 27, 2005QuickLinks
 -- Click here to rapidly navigate through this document
  

 
 

Exhibit 10.1    
    

 
 

BENTLEY PHARMACEUTICALS, INC.
  
    2005 EQUITY AND INCENTIVE PLAN    
    

1.     Establishment and Purpose  

        The Bentley Pharmaceuticals, Inc. 2005 Equity and Incentive Plan (the "Plan") is a successor to the
following equity compensation plans: 

	(i)
	Bentley
Pharmaceuticals, Inc. Amended and Restated 1991 Stock Option Plan (the "1991 Plan");

	(ii)
	2001
Employee Stock Option Plan of Bentley Pharmaceuticals, Inc. (the "2001 Plan"); and

	(iii)
	2001
Directors' Stock Option Plan of Bentley Pharmaceuticals, Inc. (the "Directors' Plan"). 

        The
1991 Plan, the 2001 Plan, and the Directors' Plan are sometimes collectively referred to herein as the "Prior Plans". Effective as of
the date the Plan is approved by the Company's stockholders (the "Effective Date"), no further options shall be granted under the Prior Plans. However,
the provisions of the Prior Plans shall continue to apply to options granted under the Prior Plans prior to the Effective Date. In the event that the Plan is not approved by the stockholders, options
shall continue to be granted under the Prior Plans in accordance with their terms, to the extent permissible thereunder. 

        The
purpose of the Plan is to attract and retain key employees, consultants, and directors of the Company and its Affiliates, to provide an incentive for them to achieve
long-range performance goals, and to enable them to participate in the long-term growth of the Company. The Plan seeks to achieve this purpose by providing Awards in the form
of Restricted Stock, Restricted Stock Units, Cash Awards, Options (which may constitute Incentive Stock Options or Nonstatutory Stock Options) or Stock Appreciation Rights. 

2.     Definitions  

        Capitalized terms are defined in the provisions of the Plan or in Appendix 1 attached hereto, which is
incorporated in the Plan by this reference. Appendix 1 also contains a list of defined terms and reference to where their definitions appear in
the Plan. 

3.     Administration  

        The Plan shall be administered by the Committee. The Committee shall determine which eligible employees, consultants, and directors will receive Awards. The
Committee shall have authority to adopt, alter and repeal such administrative rules, guidelines and practices governing the operation of the Plan as it shall from time to time consider advisable, to
interpret the provisions of the Plan and any Award agreement, and to remedy any ambiguities or inconsistencies therein. The Committee's decisions shall be final and binding. To the extent permitted by
applicable law, the Committee may delegate to one or more executive officers of the Company the power to make Awards to Participants who are not subject to Section 16 of the Exchange Act and
all determinations under the Plan with respect thereto, provided that the Committee shall fix the maximum amount of such Awards for all such Participants and a maximum for any one Participant, and
such other features of the Awards as required by applicable law. 

1

 

4.     Eligibility  

        All employees, directors and consultants of the Company or any Affiliate are eligible to be Participants in the Plan. Incentive Stock Options may be granted only
to eligible employees of the Company or its Affiliates who are taxpayers for United States federal income tax purposes. 

5.     Stock Available for Awards  

        (a)   Amount.    Shares of Common Stock available for grants of Awards under the Plan shall
consist of (i) all shares of Common Stock remaining available on the Effective Date for grant of options under the Prior Plans, (ii) all shares of Common Stock subject to any outstanding
option under any of the Prior Plans or the Executive Options that after the Effective Date expires, terminates unexercised, or is forfeited or settled in a manner that results in fewer shares
outstanding than were subject to the option as originally granted, and (iii) all additional shares that may become available as a result of any adjustment under Section 5(b). Not more
than 5,166,828 shares shall become available under the Plan pursuant to clauses (i) and (ii) of the preceding sentence. If any Award under the Plan expires, is terminated unexercised, or
is forfeited or settled in a manner that results in fewer shares outstanding than were originally awarded, then any shares no longer subject to such Award and not issued thereunder shall again be
available for Awards under the Plan. Common Stock issued through the assumption or substitution of outstanding grants from an acquired company shall not reduce the shares available for Awards under
the Plan. Shares issued under the Plan may consist in whole or in part of authorized but unissued shares or treasury shares. 

        (b)   Adjustment.    In the event that the Committee determines that any stock dividend,
extraordinary cash dividend, recapitalization, reorganization, merger, consolidation, split-up, spin-off, combination, exchange of shares, or other transaction affects the
Common Stock such that an adjustment is required in order to preserve the benefits intended to be provided by the Plan, then the Committee (subject in the case of Incentive Stock Options to any
limitation required under the Code) shall equitably adjust any or all of (i) the number and kind of shares in respect of which Awards may be made under the Plan, (ii) the number and kind
of shares subject to outstanding Awards, and (iii) the exercise price with respect to any of the foregoing, and if considered appropriate, the Committee may make provision for a cash payment
with respect to an outstanding Award, provided that the number of shares subject to any Award shall always be a whole number. 

        (c)   Limit on Individual Grants.    The maximum number of shares of Common Stock subject to
all Awards that may be granted under the Plan to any Participant in the aggregate in any calendar year shall not exceed 500,000 shares subject to adjustment under subsection (b). With respect
to any Award settled in cash that is intended to satisfy the requirements for "performance-based compensation" (within the meaning of Section 162(m)(4)(C) of the Code), no more than $5,000,000
may be paid to any one individual with respect to each year of a Performance Period. 

6.     Stock Options  

        (a)   Grant of Options.    Subject to the provisions of the Plan, the Committee may grant
options ("Options") to purchase shares of Common Stock (i) complying with the requirements of Section 422 of the Code or any successor
provision and any regulations thereunder ("Incentive Stock Options"), and (ii) not intended to comply with such requirements
("Nonstatutory Stock Options"). The Committee shall determine the number of shares subject to each Option and the exercise price therefor, which shall
not be less than 100% of the Fair Market Value of the Common Stock on the date of grant. 

        (b)   Terms and Conditions.    Each Option shall be exercisable at such times and subject to
such terms and conditions as the Committee may specify in the applicable grant or thereafter; provided that (i) no Option shall be exercisable after the expiration of ten years from the date
the Option is granted, and (ii) no Option may be granted with a reload feature which provides for an automatic grant of 

2

 

additional
or replacement options upon the exercise of an Option. The Committee may impose such conditions with respect to the exercise of Options, including conditions relating to applicable
securities laws, as it considers necessary or advisable. 

        (c)   Payment.    No shares shall be delivered pursuant to any exercise of an Option until
payment in full of the exercise price therefor is received by the Company. Such payment may be made in whole or in part in cash or to the extent permitted by the Committee at or after the grant of the
Option, pursuant to any of the following methods: (i) by actual delivery and transfer, or attestation of ownership and delivery of a valid instrument of transfer, to the Company of shares of
Common Stock owned by the Participant, including vested Restricted Stock, (ii) by retaining shares of Common Stock otherwise issuable pursuant to the Option, (iii) for consideration
received by the Company under a broker-assisted cashless exercise program acceptable to the Company, or (iv) for such other lawful consideration as the Committee may determine. 

7.     Stock Appreciation Rights  

        (a)   Grant of SARs.    Subject to the provisions of the Plan, the Committee may grant rights
to receive any excess in value of shares of Common Stock over the exercise price ("Stock Appreciation Rights" or
"SARs") in tandem with an Option (at or after the award of the Option), or alone and unrelated to an Option. SARs in tandem with an Option shall
terminate to the extent that the related Option is exercised, and the related Option shall terminate to the extent that the tandem SARs are exercised. The Committee shall determine at the time of
grant or thereafter whether SARs are settled in cash, Common Stock or other securities of the Company, Awards or other property. 

        (b)   Exercise Price.    The Committee shall fix the exercise price of each SAR or specify
the manner in which the price shall be determined. An SAR granted in tandem with an Option shall have an exercise price not less than the exercise price of the related Option. An SAR granted alone and
unrelated to an Option may not have an exercise price less than 100% of the Fair Market Value of the Common Stock on the date of the grant. 

        (c)   Limited SARs.    An SAR related to an Option, which SAR can only be exercised upon or
during limited periods following a change in control of the Company, may entitle the Participant to receive an amount based upon the highest price paid or offered for Common Stock in any transaction
relating to the change in control or paid during a specified period immediately preceding the occurrence of the change in control in any transaction reported in the stock market in which the Common
Stock is normally traded. 

8.     Restricted Stock and Restricted Stock Units  

        (a)   Grant of Restricted Stock.    Subject to the provisions of the Plan, the Committee may
grant shares of Common Stock subject to forfeiture ("Restricted Stock") and determine the duration of the period (the
"Restricted Period") during which, and the conditions under which, the shares may be forfeited to the Company and the other terms and conditions of such
Awards. Shares of Restricted Stock may be issued for no cash consideration or such minimum consideration as may be required by applicable law. 

        (b)   Restrictions.    Shares of Restricted Stock may not be sold, assigned, transferred,
pledged or otherwise encumbered, except as permitted by the Committee, during the Restricted Period. Shares of Restricted Stock shall be evidenced in such manner as the Committee may determine. Any
certificates issued in respect of shares of Restricted Stock shall be registered in the name of the Participant and unless otherwise determined by the Committee, deposited by the Participant, together
with a stock power endorsed in blank, with the Company. At the expiration of the Restricted Period, the Company shall deliver such certificates to the Participant or, if the Participant has died, to
the Participant's Designated Beneficiary. 

3

 

        (c)   Restricted Stock Units.    Subject to the provisions of the Plan, the Committee may
grant the right to receive in the future shares of Common Stock subject to forfeiture ("Restricted Stock Units") and determine the duration of the
Restricted Period during which, and the conditions under which, the Award may be forfeited to the Company and the other terms and conditions of such Awards. Restricted Stock Unit Awards shall
constitute an unfunded and unsecured obligation of the Company, and shall be settled in shares of Common Stock or cash, as determined by the Committee at the time of grant or thereafter. Such Awards
shall be made in the form of "units" with each unit representing the equivalent of one share of Common Stock. 

9.     General Provisions Applicable to Awards  

        (a)   Transferability.    Except as otherwise provided in this Section 9(a), an Award
(i) shall not be transferable other than as designated by the Participant by will or by the laws of descent and distribution, and (ii) may be exercised during the Participant's lifetime
only by the Participant or by the Participant's guardian or legal representative. In the discretion of the Committee, any Award may be transferable upon such terms and conditions and to such extent as
the Committee determines at or after grant, provided that Incentive Stock Options may be transferable only to the extent permitted by the Code. 

        (b)   Documentation.    Each Award under the Plan shall be evidenced by a writing delivered
to the Participant specifying the terms and conditions thereof and containing such other terms and conditions not inconsistent with the provisions of the Plan as the Committee considers necessary or
advisable to achieve the purposes of the Plan or to comply with applicable tax and regulatory laws and accounting principles. 

        (c)   Committee Discretion.    Each type of Award may be made alone, in addition to or in
relation to any other Award. The terms of each type of Award need not be identical, and the Committee need not treat Participants uniformly. In addition to the authority granted to the Committee in
Section 9(l) to make Awards to Covered Employees which qualify as "performance-based compensation" for purposes of Section 162(m) of the Code, the Company may grant Awards subject to
such performance conditions (including performance-based vesting) as it shall determine in its discretion. Except as otherwise provided by the Plan or a particular Award, any determination with
respect to an Award may be made by the Committee at the time of grant or at any time thereafter. 

        (d)   Dividends and Cash Awards.    In the discretion of the Committee, any Award under the
Plan may provide the Participant with (i) dividends or dividend equivalents payable currently or deferred with or without interest, and (ii) cash payments in lieu of or in addition to an
Award. 

        (e)   Termination of Employment or Service.    The Committee shall determine and set forth in
the grant agreement evidencing the Award the effect on an Award of the disability, death, retirement or other termination of employment or service of a Participant and the extent to which, and the
period during which, the Participant's legal representative, guardian or Designated Beneficiary may receive payment of an Award or exercise rights thereunder. Unless the Committee provides otherwise
in any case, a Participant's employment or service shall have terminated for purposes of the Plan at the time the entity by which the Participant is employed or to which the Participant renders
service ceases to be an Affiliate of the Company. 

        (f)    Change in Control.    In order to preserve a Participant's rights under an Award in the
event of a change in control of the Company as defined by the Committee (a "Change in Control"), the Committee in its discretion may, at the time an Award is made or at any time thereafter, take one
or more of the following actions: (i) provide for the acceleration of any time period relating to the exercise or payment of the Award, (ii) provide for payment to the Participant of
cash or other property with a Fair Market Value equal to the amount that would have been received upon the exercise or payment of the Award had the Award been exercised or paid upon the Change in
Control, (iii) adjust 

4

 

the
terms of the Award in a manner determined by the Committee to reflect the Change in Control, (iv) cause the Award to be assumed, or new rights substituted therefor, by another entity, or
(v) make such other provision as the Committee may consider equitable to Participants and in the best interests of the Company. 

        (g)   Loans.    Except for loans to reporting Persons, which are not authorized hereunder,
the Committee may authorize the making of loans to Participants in connection with the grant or exercise of any Award under the Plan. 

        (h)   Withholding Taxes.    The Participant shall pay to the Company, or make provision
satisfactory to the Committee for payment of, any taxes required by law to be withheld in respect of Awards under the Plan no later than the date of the event creating the tax liability. In the
Committee's discretion, such tax obligations may be paid in whole or in part in shares of Common Stock, including shares retained from the Award creating the tax obligation, valued at their Fair
Market Value on the date of delivery. The Company and its Affiliates may, to the extent permitted by law, deduct any such tax obligations from any payment of any kind otherwise due to the Participant. 

        (i)    Foreign National Awards.    Notwithstanding anything to the contrary contained in the
Plan, Awards may be made to Participants who are foreign nationals or employed or performing services outside the United States on such terms and conditions different from those specified in the Plan
as the Committee considers necessary or advisable to achieve the purposes of the Plan or to comply with applicable laws. 

        (j)    Amendment of Award.    Except as provided in Section 9(k), the Committee may
amend, modify or terminate any outstanding Award, including substituting therefor another Award of the same or a different type, changing the date of exercise or realization, and converting an
Incentive Stock Option to a Nonstatutory Stock Option, provided that the Participant's consent to such action shall be required unless (i) the Committee determines that the action, taking into
account any related action, would not materially and adversely affect the Participant, or (ii) the action is permitted by the terms of the Plan. 

        (k)   No Repricing of Options.    Notwithstanding anything to the contrary in the Plan, the
Company shall not engage in any repricing of Options granted under the Plan (including those granted under the Prior Plans and the Executive Options) without further stockholder approval. For this
purpose, the term "repricing" shall mean any of the following or other action that has the same effect: (i) lowering the exercise price of an Option after it is granted, (ii) any other
action that is treated as a repricing under generally accepted accounting principles, or (iii) canceling an Option at a time when its exercise price exceeds the fair market value of the
underlying stock in exchange for another Option, Restricted Stock, or other equity of the Company, unless the cancellation and exchange occurs in connection with a merger, acquisition,
spin-off, or similar corporate transaction. 

        (l)    Code Section 162(m) Provisions.    If the Committee determines at the time an
Award is granted to a Participant that such Participant is, or may be as of the end of the tax year for which the Company would claim a tax deduction in connection with such Award, a Covered Employee,
then the Committee may provide that the Participant's right to receive cash, Shares, or other property pursuant to such Award shall be subject to the satisfaction of Performance Goals during a
Performance Period. Prior to the payment of any Award subject to this Section 9(l), the Committee shall certify in writing that the Performance Goals and other material terms applicable to such
Award were satisfied. Notwithstanding the attainment of Performance Goals by a Covered Employee, the Committee shall have the right to reduce (but not to increase) the amount payable at a given level
of performance to take into account additional factors that the Committee may deem relevant. The Committee shall have the power to impose such other restrictions on Awards subject to this
Section 9(l) as it may deem necessary or appropriate to ensure that such Awards satisfy all requirements for "performance-based compensation" within the meaning of Section 162(m) of the
Code. 

5

 

10.   Miscellaneous  

        (a)   No Right To Employment.    No person shall have any claim or right to be granted an
Award. Neither the Plan nor any Award hereunder shall be deemed to give any employee the right to continued employment or service or to limit the right of the Company to discharge any Participant at
any time. 

        (b)   No Rights As Stockholder.    Subject to the provisions of the applicable Award, no
Participant or Designated Beneficiary shall have any rights as a stockholder with respect to any shares of Common Stock to be distributed under the Plan until he or she becomes the holder thereof. A
Participant to whom Common Stock is awarded shall be considered the holder of the Stock at the time of the Award except as otherwise provided in the applicable Award. 

        (c)   Effective Date.    The Plan shall become effective on the Effective Date. 

        (d)   Amendment and Term of Plan.    The Board may amend, suspend or terminate the Plan or
any portion thereof at any time, subject to such stockholder approval as the Board determines to be necessary or advisable to comply with any tax or regulatory requirement. Unless terminated earlier
by the Board or extended by subsequent approval of the Company's stockholders, the term of the Plan shall expire at the close of business on the date immediately preceding the tenth anniversary of the
date on which the Plan was originally approved by stockholders, and no further Awards shall be made thereafter. 

        (e)   Governing Law.    The provisions of the Plan shall be governed by and interpreted in
accordance with the laws of Delaware. 

The Plan was adopted by the Board of Directors on March 30, 2005.  

The Plan was approved by the stockholders on May 24, 2005.  

6

  

 
 

Appendix 1    
    

        "1991 Plan"—See Section 1. 

        "2001 Plan"—See Section 1. 

        "Affiliate" means any business entity in which the Company owns directly or indirectly 50% or more of the total voting power or has a
significant financial interest as determined by the Committee. 

        "Award" means any Option, Stock Appreciation Right, Restricted Stock, Restricted Stock Unit, Cash Award, or Foreign National Award granted
under the Plan. 

        "Board" means the Board of Directors of the Company. 

        "Cash Award"—See Section 9(d). 

        "Code" means the Internal Revenue Code of 1986, as amended from time to time, or any successor law. 

        "Committee" means one or more committees each comprised of not less than three members of the Board appointed by the Board to administer
the Plan or a specified portion thereof. If a Committee is authorized to grant Awards to a Reporting Person or a Covered Employee, each member shall be a "disinterested person" or the equivalent
within the meaning of applicable Rule 16b-3 under the Exchange Act or an "outside director" or the equivalent within the meaning of Section 162(m) of the Code, respectively. 

        "Common Stock" or "Stock" means the Common Stock,  $.02 par value, of the Company. 

        "Company" means Bentley Pharmaceuticals, Inc. 

        "Covered Employee" means a "covered employee" within the meaning of Section 162(m)
of the Code. 

        "Designated Beneficiary" means the beneficiary designated by a Participant, in a manner determined by the Committee, to receive amounts
due or exercise rights of the Participant in the event of the Participant's death. In the absence of an effective designation by a Participant, "Designated
Beneficiary" means the Participant's estate. 

        "Directors' Plan"—See Section 1. 

        "Effective Date"—See Section 1. 

        "Exchange Act" means the Securities Exchange Act of 1934, as amended from time to time, or any successor law. 

        "Executive Options"—means options granted and approved by Bentley stockholders in 1996 to Bentley's then executive officers,
Messrs. Murphy, Price and Stote, outside of any stock option plan. 

        "Fair Market Value" means, with respect to Common Stock or any other property, the fair market value of such property as determined by the
Committee in good faith or in the manner established by the Committee from time to time. 

        "Foreign National Award"—See Section 9(i). 

        "Incentive Stock Option"—See Section 6(a). 

        "Nonstatutory Stock Option"—See Section 6(a). 

        "Option"—See Section 6(a). 

        "Participant" means a person selected by the Committee to receive an Award under the Plan. 

A-1

 

        "Performance Goals" means with respect to any Performance Period, one or more objective performance goals based on one or more of the
following objective criteria established by the Committee prior to the beginning of such Performance Period or within such period after the beginning of the Performance Period as shall meet the
requirements to be considered "pre-established performance goals" for purposes of Code Section 162(m): (i) increases in the price of the Common stock, (ii) market
share, (iii) sales, (iv) revenue, (v) return on equity, assets, or capital, (vi) economic profit (economic value added), (vii) total shareholder return,
(viii) costs, (ix) expenses, (x) margins, (xi) earnings or earnings per share, (xii) cash flow, (xiii) customer satisfaction, (xiv) operating profit,
(xv) research and development, (xvi) product development, (xvii) manufacturing, or (xviii) any combination of the foregoing, including without limitation, goals based on
any of such measures relative to appropriate peer groups or market indices. Such Performance Goals may be particular to a Participant or may be based, in whole or in part, on the performance of the
Company generally or on the performance of the division, department, line of business, subsidiary, or other business unit, whether or not legally constituted, in which the Participant works. 

        "Performance Period" means the period of service designated by the Committee applicable to an Award subject to Section 9(l) for
which the Performance Goals will be measured. 

        "Plan" means the Bentley Pharmaceuticals, Inc. 2005 Equity and Incentive Plan. 

        "Prior Plans"—See Section 1. 

        "Reporting Person" means a person subject to reporting under Section 16 of the Exchange Act. 

        "Restricted Period"—See Section 8(a). 

        "Restricted Stock"—See Section 8(a). 

        "Restricted Stock Unit"—See Section 8(c) 

        "Stock Appreciation Right" or "SAR"—See Section 7(a). 

A-2

QuickLinks

Exhibit 10.1

BENTLEY PHARMACEUTICALS, INC. 2005 EQUITY AND INCENTIVE PLAN

Appendix 1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}]]